Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Hemorrhage 5 Hematologic Neoplasms 3 Head and Neck Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Postoperative Complications 1 Osteosarcoma 1 Myofibroma 1 Metrorrhagia 1 Meningioma 1 Melanoma 1 Leiomyoma 1 Glioma 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Radiotherapy 8 Temozolomide 7 Lomustine 6 Procarbazine 4 Carmustine 4 Bevacizumab 4 Vincristine 3 Surgical Procedures, Operative 2 Administration, Oral 2 vorasidenib 1 fluorodopa F 18 1 contrast agent BR1 1 carmustine, poliferprosan 20 drug combination 1 Valproic Acid 1 Tranexamic Acid 1 Trabedersen 1 TIC10 compound 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Microbubbles 1 Methylphenidate 1 Methods 1 Isotretinoin 1 Infusions, Intravenous 1 IL13-PE38 1 Fentanyl 1 Eflornithine 1 Drug Delivery Systems 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Glioma × Tranexamic Acid × Clear all

NCT01655927 2012-08-02

COLFIRE

Colombian Foundation for Epilepsy and Neurological Disease

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioma, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡